Integrating socio-economic support into drug-resistant TB care to optimise treatment outcomes
BACKGROUND: Drug-resistant TB (DR-TB) remains a public health concern in Kenya, with an estimated 2,500 individuals acquiring DR-TB annually. Despite significant progress in DR-TB management, the treatment success rate (TSR) in 2021 stood at 77%, falling short of the 85% target. This low TSR occurs...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
International Union Against Tuberculosis and Lung Disease (The Union)
2025-01-01
|
Series: | IJTLD Open |
Subjects: | |
Online Access: | https://www.ingentaconnect.com/contentone/iuatld/ijtldo/2025/00000002/00000001/art00007 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832590464393412608 |
---|---|
author | J. Limo C. Pahe I. Kathure L. Ndungu A. Mahihu C. Mwashumbe E. Mueni H. Momanyi |
author_facet | J. Limo C. Pahe I. Kathure L. Ndungu A. Mahihu C. Mwashumbe E. Mueni H. Momanyi |
author_sort | J. Limo |
collection | DOAJ |
description | BACKGROUND: Drug-resistant TB (DR-TB) remains a public health concern in Kenya, with an estimated 2,500 individuals acquiring DR-TB annually. Despite significant progress in DR-TB management, the treatment success rate (TSR) in 2021 stood at 77%, falling short of the 85% target. This low TSR occurs amidst a complex range of treatment challenges, including psychosocial factors. The aim of this study was to assess the impact of integrating psychosocial and economic empowerment interventions into standard DR-TB care. METHODS: A convergent mixed-method approach was employed, involving interviews with 217 participants, including persons with DR-TB and key stakeholders, using a structured questionnaire. The study was conducted in Kenya’s two highest DR-TB burden counties between October and November 2023. RESULTS: The study found that 55% of respondents experienced psychological depression during treatment, with financial constraints identified as the primary trigger (70.6%). Only 49% of persons with DR-TB joined psychosocial support groups, and of these, 90% demonstrated improved treatment adherence. Additionally, individuals with DR-TB who participated in income-generating activities had a treatment adherence rate of 95%, compared to 88% among those not engaged in such activities. CONCLUSION: Patient-centred approaches involving socio-economic support systems are crucial in addressing treatment adherence barriers, thereby leading to improved treatment outcomes. |
format | Article |
id | doaj-art-54b2a87513c044728cd425f8a9ba651a |
institution | Kabale University |
issn | 3005-7590 |
language | English |
publishDate | 2025-01-01 |
publisher | International Union Against Tuberculosis and Lung Disease (The Union) |
record_format | Article |
series | IJTLD Open |
spelling | doaj-art-54b2a87513c044728cd425f8a9ba651a2025-01-23T13:39:30ZengInternational Union Against Tuberculosis and Lung Disease (The Union)IJTLD Open3005-75902025-01-0121333810.5588/ijtldopen.24.05347Integrating socio-economic support into drug-resistant TB care to optimise treatment outcomesJ. Limo0C. Pahe1I. Kathure2L. Ndungu3A. Mahihu4C. Mwashumbe5E. Mueni6H. Momanyi7Population Services Kenya, Nairobi, Kenya;Population Services Kenya, Nairobi, Kenya;National Tuberculosis Programme, Nairobi, Kenya;Population Services Kenya, Nairobi, Kenya;Population Services Kenya, Nairobi, Kenya;Mombasa County Government, Mombasa, Kenya;Nairobi County Government, Nairobi, Kenya.Population Services Kenya, Nairobi, Kenya;BACKGROUND: Drug-resistant TB (DR-TB) remains a public health concern in Kenya, with an estimated 2,500 individuals acquiring DR-TB annually. Despite significant progress in DR-TB management, the treatment success rate (TSR) in 2021 stood at 77%, falling short of the 85% target. This low TSR occurs amidst a complex range of treatment challenges, including psychosocial factors. The aim of this study was to assess the impact of integrating psychosocial and economic empowerment interventions into standard DR-TB care. METHODS: A convergent mixed-method approach was employed, involving interviews with 217 participants, including persons with DR-TB and key stakeholders, using a structured questionnaire. The study was conducted in Kenya’s two highest DR-TB burden counties between October and November 2023. RESULTS: The study found that 55% of respondents experienced psychological depression during treatment, with financial constraints identified as the primary trigger (70.6%). Only 49% of persons with DR-TB joined psychosocial support groups, and of these, 90% demonstrated improved treatment adherence. Additionally, individuals with DR-TB who participated in income-generating activities had a treatment adherence rate of 95%, compared to 88% among those not engaged in such activities. CONCLUSION: Patient-centred approaches involving socio-economic support systems are crucial in addressing treatment adherence barriers, thereby leading to improved treatment outcomes.https://www.ingentaconnect.com/contentone/iuatld/ijtldo/2025/00000002/00000001/art00007adherencemental healthperson-centred care |
spellingShingle | J. Limo C. Pahe I. Kathure L. Ndungu A. Mahihu C. Mwashumbe E. Mueni H. Momanyi Integrating socio-economic support into drug-resistant TB care to optimise treatment outcomes IJTLD Open adherence mental health person-centred care |
title | Integrating socio-economic support into drug-resistant TB care to optimise treatment outcomes |
title_full | Integrating socio-economic support into drug-resistant TB care to optimise treatment outcomes |
title_fullStr | Integrating socio-economic support into drug-resistant TB care to optimise treatment outcomes |
title_full_unstemmed | Integrating socio-economic support into drug-resistant TB care to optimise treatment outcomes |
title_short | Integrating socio-economic support into drug-resistant TB care to optimise treatment outcomes |
title_sort | integrating socio economic support into drug resistant tb care to optimise treatment outcomes |
topic | adherence mental health person-centred care |
url | https://www.ingentaconnect.com/contentone/iuatld/ijtldo/2025/00000002/00000001/art00007 |
work_keys_str_mv | AT jlimo integratingsocioeconomicsupportintodrugresistanttbcaretooptimisetreatmentoutcomes AT cpahe integratingsocioeconomicsupportintodrugresistanttbcaretooptimisetreatmentoutcomes AT ikathure integratingsocioeconomicsupportintodrugresistanttbcaretooptimisetreatmentoutcomes AT lndungu integratingsocioeconomicsupportintodrugresistanttbcaretooptimisetreatmentoutcomes AT amahihu integratingsocioeconomicsupportintodrugresistanttbcaretooptimisetreatmentoutcomes AT cmwashumbe integratingsocioeconomicsupportintodrugresistanttbcaretooptimisetreatmentoutcomes AT emueni integratingsocioeconomicsupportintodrugresistanttbcaretooptimisetreatmentoutcomes AT hmomanyi integratingsocioeconomicsupportintodrugresistanttbcaretooptimisetreatmentoutcomes |